Agent Capital invests where molecules, milestones and money collide. Its small team backs healthcare companies across the development curve, then stays close enough to help science become a financeable business.
Seae Ventures was built by healthcare insiders who saw two blind spots at once: patients the system underserved and founders the funding system overlooked. Its answer is a portfolio designed around access, outcomes and the practical machinery of care.
Global Health Impact Network & Funds has built a venture firm around a simple correction: let clinicians judge healthcare technology before the market does. Its network supplies the expertise, the diligence and, increasingly, the capital.
Wavemaker 360 built a healthcare-only venture firm around an unusually practical idea: the people funding the portfolio can also help its founders enter the rooms where healthcare gets bought.
Andy Slavitt ran Medicare. Now he runs a $1.4 billion fund arguing that the patients Wall Street ignores are where the money is - and the math, so far, agrees.
Flare Capital has nearly $1 billion under management. Its sharper pitch is a network that turns healthcare's guarded buyers into advisers, pilot partners and customers.
HC9 Ventures built its pitch around a simple diagnosis: healthcare startups rarely fail for lack of software alone. They fail in the maze between a promising product and the institutions that must buy, trust, and deploy it.